UGCG and hepatocellular carcinoma: Here, we demonstrate the impact of the GCS inhibitor Genz and the CAD and anti-psychotic drug aripiprazole, together with sorafenib and the DNA-intercalating agent doxorubicin [46], on the growth of Huh7 and Hepa 1-6 hepatocellular cancer cells and cancer spheroids.